- $3.47bn
- $3.18bn
- $330.48m
- 86
- 15
- 83
- 65
Annual income statement for Avepoint, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 152 | 192 | 232 | 272 | 330 |
Cost of Revenue | |||||
Gross Profit | 111 | 139 | 166 | 194 | 248 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 167 | 245 | 273 | 287 | 323 |
Operating Profit | -15.4 | -53.5 | -41.1 | -15.4 | 7.17 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.9 | -32.8 | -33.6 | -18.6 | -24.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17 | -33.2 | -38.7 | -21.5 | -29.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -17 | -35.2 | -41.6 | -21.7 | -29.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -51.4 | -68.1 | -41.6 | -21.7 | -29.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.285 | -0.481 | -0.229 | -0.119 | -0.158 |
Dividends per Share |